The tech revolution has been upon us for decades, whether it was the boom in televisions, computers or cell phones. More recently, AI is firmly in the spotlight, alongside more developments in other products.
To help you understand the market, our highly experienced Kiplinger Letter team will keep you abreast of developments in the tech sector (Get a free issue of The Kiplinger Letter or subscribe). You will get all the latest news first by subscribing, but we will publish many of the forecasts a few days afterward online. Here’s the latest…
Here's another sign that the tech spending boom has returned to earth: Tablet shipments are back to normal, after a surge during the pandemic among buyers rushing to buy the portable devices for remote work and play.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Market research firm IDC reports that global shipments in the first quarter of 2023 were 30.1 million units, close to the 31.6 million shipped in the first quarter of 2019.
Those preliminary figures show a 19% year-over-year decline, and demand will weaken further. The market is dominated by Apple and Samsung, which grab the majority of shipments.
Still, other vendors continue to compete, such as China’s Huawei, the third-largest seller, Lenovo takes fourth position with Amazon in fifth, seeing a drop of 62% year over year. OnePlus and Google are also launching new tablets.
Though vendors are hurt by falling sales, they are cheering huge user gains. Apple, for example, boasts that iPad users reached a new all-time high recently. The company profits from device users splurging on the company’s other services.
This forecast first appeared in The Kiplinger Letter. Since 1923, the Letter has helped millions of business executives and investors profit by providing reliable forecasts on business and the economy, as well as what to expect from Washington. Get a free issue of The Kiplinger Letter or subscribe.
-
What About Those ‘Guaranteed’ Life Insurance Ads?Guaranteed life insurance policies can sound tempting if you've been declined for insurance elsewhere. Here are four downsides and one alternative.
-
13 Answers to Pressing Social Security QuestionsFrom smart claiming strategies for couples to tips on maximizing your monthly check, we have advice that can help you.
-
Blue Collar Workers Add AI to Their ToolboxesThe Kiplinger Letter AI can’t fix a leak or install lighting, but more and more tradespeople are adopting artificial intelligence for back-office work and other tasks.
-
America's Surprising Strengths in Manufacturing and ExportsThe Kiplinger Letter Despite common perceptions that the U.S. doesn't build things anymore, American factories are still hard at work. A special report from The Kiplinger Letter.
-
Will State Laws Hurt AI’s Future?The Kiplinger Letter Republicans in Congress are considering a moratorium on state AI laws. But it’s likely a growing patchwork of state AI regulations will be here for a while.
-
The New AI Agents Will Tackle Your To-Do ListThe Kiplinger Letter Autonomous AI agents “see” your computer screen, then complete a task, from buying a concert ticket to organizing email. This opens up a world of possibilities.
-
AI’s Medical RevolutionThe Kiplinger Letter Medicine is a field ripe for finding both exciting and practical uses for AI. The tech is already being used by doctors and researchers.
-
The Economic Impact of the US-China Trade WarThe Letter The US-China trade war will impact US consumers and business. The decoupling process could be messy.
-
AI Heads to WashingtonThe Kiplinger Letter There’s big opportunity for AI tools that analyze MRIs and other medical images. But also big challenges that clinicians and companies will have to overcome.
-
The AI Doctor Coming to Read Your Test ResultsThe Kiplinger Letter There’s big opportunity for AI tools that analyze CAT scans, MRIs and other medical images. But there are also big challenges that human clinicians and tech companies will have to overcome.
